Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter

Journal of the National Cancer Institute

Volumn 90, Issue 14, 1998, Pages 1080-1087

  He, Yukai ^a   Zeng, Qing ^a   Drenning, Stephanie D ^a   Melhem, Mona F ^a   Tweardy, David J ^a   Huang, Leaf ^a   Grandis, Jennifer Rubin ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOSOME; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

EID: 0032528051     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.14.1080     Document Type: Article

References (39)

1. Salomon DS, Brandt R, Ciardiello R, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995;19:183-232.
2. Davies DE, Chamberlin SG. Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochem Pharmacol 1996;51:1101-10.
3. Divigi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991;83:97-104.
4. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, et al. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993;85: 1327-33.
5. Stragliotto G, Vega F, Stasiecki P, Gropp P, Poisson M, Delattre JY. Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55 900) in patients with recurrent malignant gliomas. Eur J Cancer 1996;32:636-40.
6. Rusch V, Mendelsohn J, Dmitrovsky E. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev 1996;7:133-41.
7. Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Cancer Res 1994;54: 1008-15.
8. Pastan I, FitzGerald D. Recombinant toxins for cancer treatment. Science 1991;254:1173-7.
9. Moroni MC, Willingham MC, Beguinot L. EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J Biol Chem 1992;267:2714-22.
10. Rubin Grandis J, Chakraborty A, Melhem MF, Zeng Q, Tweardy DJ. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene 1997;15:409-16.
11. Noonberg SB, Scott GK, Garovoy MR, Benz CC, Hunt CA. In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation. Nucleic Acids Res 1994;22:2830-6.
12. He Y, Huang L. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter. Cancer Res 1997;57:3993-9.
13. Good PD, Krikos AJ, Bertrand E, Lee NS, Giver L, Ellington A, et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 1997;4:45-54.
14. Sacks PG, Parnes SM, Gallick GE, Mansouri Z, Lichtner R, Satya-Prakash KL, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988;48:2858-66.
15. Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, et al. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res 1995;55:3183-91.
16. Sorgi FL, Huang L. Large scale production of DC-Chol cationic liposomes by microfluidization. Int J Pharmaceutics 1996;144:131-9.
17. Shamanin V, Delius H, de Villiers EM. Development of a broad spectrum PCR assay for papillomavirus and its application in screening lung cancer biopsies. J Gen Virol 1994;75(Pt 5):1149-56.
18. Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996;78:1284-92.
19. Kunkel GR. RNA polymerase III transcription of genes that lack internal control regions. Biochim Biophys Acta 1991;1088:1-9.
20. Nabel EG, Gordon D, Yang ZY, Xu L, San H, Plautz GE. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gen Ther 1992;3:649-56.
21. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CH, Aaronson SA, et al. Automne interaction between TGF-α and EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 1989;4: 831-8.
22. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A 1991;88:7792-6.
23. Rubin Grandis J, Tweardy DJ. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53: 3579-84.
24. Rubin Grandis J, Zeng Q, Tweardy DJ. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nat Med 1996;2:237-40.
25. Todd R, Donoff BR, Gertz R, Chang AL, Chow P, Matossian K, et al. TGF-α and EGF receptor mRNAs in human oral cancers. Carcinogenesis 1989;10:1553-6.
26. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Otolaryngol 1993;113: 563-7.
27. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 1995; 95:1897-905.
28. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 1994;91: 7727-31.
29. Snelling L, Miyamoto CT, Bender H, Brady LW, Steplewski Z, Class R, et al. Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas. Hybridoma 1995;14:111-4.
30. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995;2:710-22.
31. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biological activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A 1993;90:11307-11.
32. Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis [published erratum appears in Nat Med 1995;1: 272]. Nat Med 1995;1:39-46.
33. Vlock DR, Snyderman CH, Johnson JT, Myers EN, Eibling DE, Rubin JS, et al. Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial. J Immunother Emphasis Tumor Immunol 1994;15:134-9.
34. Forastiere AA, Urba SG. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer. Semin Oncol 1995;22(3 Suppl 6):24-7.
35. Scherczinger CA, Yates AA, Knecht DA. Variables affecting antisense RNA inhibition of gene expression. Ann N Y Acad Sci 1992;660:45-56.
36. Sauterer RA, Feeney RJ, Zieve GW. Cytoplasmic assembly of snRNP particles from stored proteins and newly transcribed snRNA's in L929 mouse fibroblasts. Exp Cell Res 1988;176:344-59.
37. Kunkel GR, Pederson T. Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box. Nucleic Acids Res 1989;17:7371-9.
38. Singh R, Gupta S, Reddy R. Capping of mammalian U6 small nuclear RNA in vitro is directed by a conservative stem-loop and AUAUAC sequence: conversion of a noncapped RNA into a capped RNA. Mol Cell Biol 1990; 10:939-46.
39. Shumyatsky G, Wright D, Reddy R. Methylphosphate cap structure increases the stability of 7SK, B2 and U6 small RNAs in Xenopus oocytes. Nucleic Acids Res 1993;21:4756-61.